BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 9915863)

  • 1. Role of Egr-2 in up-regulation of Fas ligand in normal T cells and aberrant double-negative lpr and gld T cells.
    Mittelstadt PR; Ashwell JD
    J Biol Chem; 1999 Jan; 274(5):3222-7. PubMed ID: 9915863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Egr family members regulate nonlymphoid expression of Fas ligand, TRAIL, and tumor necrosis factor during immune responses.
    Droin NM; Pinkoski MJ; Dejardin E; Green DR
    Mol Cell Biol; 2003 Nov; 23(21):7638-47. PubMed ID: 14560009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity exhibited by Fas ligand (CD95L) overexpressed on lymphoid cells against Fas+ tumor cells.
    Shimizu M; Takeda Y; Yagita H; Yoshimoto T; Matsuzawa A
    Cancer Immunol Immunother; 1998 Nov; 47(3):143-8. PubMed ID: 9829839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-derived Fas ligand induces toxicity in lymphoid organs and plays an important role in successful chemotherapy.
    Nagarkatti N
    Cancer Immunol Immunother; 2000 Apr; 49(1):46-55. PubMed ID: 10782865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis.
    Kuwano K; Hagimoto N; Kawasaki M; Yatomi T; Nakamura N; Nagata S; Suda T; Kunitake R; Maeyama T; Miyazaki H; Hara N
    J Clin Invest; 1999 Jul; 104(1):13-9. PubMed ID: 10393694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection from autoimmune diabetes and T-cell lymphoproliferation induced by FasL mutation are differentially regulated and can be uncoupled pharmacologically.
    Mohamood AS; Guler ML; Xiao Z; Zheng D; Hess A; Wang Y; Yagita H; Schneck JP; Hamad AR
    Am J Pathol; 2007 Jul; 171(1):97-106. PubMed ID: 17591957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RORgamma t, a novel isoform of an orphan receptor, negatively regulates Fas ligand expression and IL-2 production in T cells.
    He YW; Deftos ML; Ojala EW; Bevan MJ
    Immunity; 1998 Dec; 9(6):797-806. PubMed ID: 9881970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FasL is a catabolic factor in alveolar bone homeostasis.
    Apaza Alccayhuaman KA; Heimel P; Lee JS; Tangl S; Kuchler U; Marchesan J; Panahipour L; Lettner S; Matalová E; Gruber R
    J Clin Periodontol; 2023 Mar; 50(3):396-405. PubMed ID: 36384160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FasL impacts Tgfb signaling in osteoblastic cells.
    Kratochvilova A; Knopfova L; Gregorkova J; Gruber R; Janeckova E; Chai Y; Matalova E
    Cells Dev; 2024 May; ():203929. PubMed ID: 38810946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGR2 is elevated and positively regulates inflammatory IFNγ production in lupus CD4
    Dai R; Heid B; Xu X; Xie H; Reilly CM; Ahmed SA
    BMC Immunol; 2020 Jul; 21(1):41. PubMed ID: 32646370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immediate Early Genes Anchor a Biological Pathway of Proteins Required for Memory Formation, Long-Term Depression and Risk for Schizophrenia.
    Marballi KK; Gallitano AL
    Front Behav Neurosci; 2018; 12():23. PubMed ID: 29520222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A transcription factor map as revealed by a genome-wide gene expression analysis of whole-blood mRNA transcriptome in multiple sclerosis.
    Riveros C; Mellor D; Gandhi KS; McKay FC; Cox MB; Berretta R; Vaezpour SY; Inostroza-Ponta M; Broadley SA; Heard RN; Vucic S; Stewart GJ; Williams DW; Scott RJ; Lechner-Scott J; Booth DR; Moscato P;
    PLoS One; 2010 Dec; 5(12):e14176. PubMed ID: 21152067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGR-2 is not required for in vivo CD4 T cell mediated immune responses.
    Ramón HE; Cejas PJ; LaRosa D; Rahman A; Harris JE; Zhang J; Hunter C; Choi Y; Turka LA
    PLoS One; 2010 Sep; 5(9):e12904. PubMed ID: 20886122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and biochemical regulation of CD4 T cell effector differentiation: insights from examination of T cell clonal anergy.
    Gamper CJ; Powell JD
    Immunol Res; 2010 Jul; 47(1-3):162-71. PubMed ID: 20077160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The HECT-type E3 ubiquitin ligase AIP2 inhibits activation-induced T-cell death by catalyzing EGR2 ubiquitination.
    Chen A; Gao B; Zhang J; McEwen T; Ye SQ; Zhang D; Fang D
    Mol Cell Biol; 2009 Oct; 29(19):5348-56. PubMed ID: 19651900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Many checkpoints on the road to cell death: regulation of Fas-FasL interactions and Fas signaling in peripheral immune responses.
    Ramaswamy M; Cleland SY; Cruz AC; Siegel RM
    Results Probl Cell Differ; 2009; 49():17-47. PubMed ID: 19132321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early growth response genes regulate B cell development, proliferation, and immune response.
    Gururajan M; Simmons A; Dasu T; Spear BT; Calulot C; Robertson DA; Wiest DL; Monroe JG; Bondada S
    J Immunol; 2008 Oct; 181(7):4590-602. PubMed ID: 18802061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early growth response gene 2 (Egr-2) controls the self-tolerance of T cells and prevents the development of lupuslike autoimmune disease.
    Zhu B; Symonds AL; Martin JE; Kioussis D; Wraith DC; Li S; Wang P
    J Exp Med; 2008 Sep; 205(10):2295-307. PubMed ID: 18779345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent antigenic stimulation alters the transcription program in T cells, resulting in antigen-specific tolerance.
    Anderson PO; Manzo BA; Sundstedt A; Minaee S; Symonds A; Khalid S; Rodriguez-Cabezas ME; Nicolson K; Li S; Wraith DC; Wang P
    Eur J Immunol; 2006 Jun; 36(6):1374-85. PubMed ID: 16708405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcineurin/NFAT-induced up-regulation of the Fas ligand/Fas death pathway is involved in methamphetamine-induced neuronal apoptosis.
    Jayanthi S; Deng X; Ladenheim B; McCoy MT; Cluster A; Cai NS; Cadet JL
    Proc Natl Acad Sci U S A; 2005 Jan; 102(3):868-73. PubMed ID: 15644446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.